Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study of Suizenji in Patients With Unresectable Pancreatic Cancer

NCT05601323 is registered in ClinicalTrials.gov with SONIRE Therapeutics Inc. as lead sponsor.

NCT NCT05601323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05601323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study of Suizenji in Patients With Unresectable Pancreatic Cancer
Lead sponsor
SONIRE Therapeutics Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 31, 2023
Completion date
May 31, 2027
Enrollment
90 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable pancreatic cancer